Cargando…

Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis

Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Shamik, Kaswala, Dharmesh, Patel, Nishith, Sood, Sunita, Brelvi, Zamir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649867/
https://www.ncbi.nlm.nih.gov/pubmed/26664852
http://dx.doi.org/10.4103/2249-4863.123944
_version_ 1782401434102267904
author Shah, Shamik
Kaswala, Dharmesh
Patel, Nishith
Sood, Sunita
Brelvi, Zamir
author_facet Shah, Shamik
Kaswala, Dharmesh
Patel, Nishith
Sood, Sunita
Brelvi, Zamir
author_sort Shah, Shamik
collection PubMed
description Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclopramide and erythromycin to reprogram gastric motility can delay or even avoid the need for gastric electrical stimulants. This case report focuses on a patient with severe gastroparesis, who was considered for a gastric pacemaker implantation and was instead treated successfully with “Pulse Therapy.” As a part of this regimen, he was given metoclopramide continuously for 3 months along with pulses of erythromycin for 10 days a month for 3 months. Patient recovered dramatically that he no longer remained a candidate for gastric pacemaker implantation. This case study emphasizes on how the proper use of prokinetic agents based on symptoms and gastric emptying study can reprogram the stomach motility in these patients with severe gastroparesis.
format Online
Article
Text
id pubmed-4649867
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46498672015-12-10 Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis Shah, Shamik Kaswala, Dharmesh Patel, Nishith Sood, Sunita Brelvi, Zamir J Family Med Prim Care Case Report Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclopramide and erythromycin to reprogram gastric motility can delay or even avoid the need for gastric electrical stimulants. This case report focuses on a patient with severe gastroparesis, who was considered for a gastric pacemaker implantation and was instead treated successfully with “Pulse Therapy.” As a part of this regimen, he was given metoclopramide continuously for 3 months along with pulses of erythromycin for 10 days a month for 3 months. Patient recovered dramatically that he no longer remained a candidate for gastric pacemaker implantation. This case study emphasizes on how the proper use of prokinetic agents based on symptoms and gastric emptying study can reprogram the stomach motility in these patients with severe gastroparesis. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC4649867/ /pubmed/26664852 http://dx.doi.org/10.4103/2249-4863.123944 Text en Copyright: © Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shah, Shamik
Kaswala, Dharmesh
Patel, Nishith
Sood, Sunita
Brelvi, Zamir
Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title_full Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title_fullStr Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title_full_unstemmed Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title_short Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
title_sort reprogramming of gastric motility with “pulse therapy” (metoclopramide and erythromycin) in severe gastroparesis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649867/
https://www.ncbi.nlm.nih.gov/pubmed/26664852
http://dx.doi.org/10.4103/2249-4863.123944
work_keys_str_mv AT shahshamik reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis
AT kaswaladharmesh reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis
AT patelnishith reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis
AT soodsunita reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis
AT brelvizamir reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis